Evidence map›Paper›PMID 22220178›Full record

ArticleStem cells international2012

The potential of stem cells in the treatment of skeletal muscle injury and disease.

S Maclean, W S Khan, A A Malik, S Anand, M Snow

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Stem cells international, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03067831 (Safety and Efficacy of Purified Autologous Bone Marrow-Derived Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy.), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03067831 phase1 / phase2unknown statusnot on this mapstarted 2015, after this paper: background citation

Safety and Efficacy of Purified Autologous Bone Marrow-Derived Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy.

TypeinterventionalSponsorStem Cells ArabiaRan2015 to 2021Enrolled20ConditionsDuchenne Muscular DystrophyArmsStem Cells
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Sexual dimorphisms in skeletal muscle: current concepts and research horizons.Journal of applied physiology (Bethesda, Md. : 1985) · 2024
    Review
  3. Article
  4. The regenerative potential of Pax3/Pax7 on skeletal muscle injury.Journal, genetic engineering & biotechnology · 2022
    Review
  5. Article
  6. Muscle Injury: Pathophysiology, Diagnosis, and Treatment.Revista brasileira de ortopedia · 2022
    Article
  7. Article
  8. Muscle stem cells: what's new in orthopedics?Acta bio-medica : Atenei Parmensis · 2019
    Review
  9. Article
  10. Article
  11. Duchenne muscular dystrophy: current cell therapies.Therapeutic advances in neurological disorders · 2015
    Review
  12. Biophysical cues enhance myogenesis of human adipose derived stem/stromal cells.Biochemical and biophysical research communications · 2013
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

S MacleanUniversity of Manchester, Manchester M13 9PL, UK.
W S Khan
A A Malik
S Anand
M Snow
Royal National Orthopaedic Hospital · GBStepping Hill Hospital · GBUniversity College London · GBUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tissue engineering is a pioneering field with huge advances in recent times. These advances are not only in the understanding of how cells can be manipulated but also in potential clinical applications. Thus, tissue engineering, when applied to skeletal muscle cells, is an area of huge prospective benefit to patients with muscle disease/damage. This could include damage to muscle from trauma and include genetic abnormalities, for example, muscular dystrophies. Much of this research thus far has been focused on satellite cells, however, mesenchymal stem cells have more recently come to the fore. In particular, results of trials and further research into their use in heart failure, stress incontinence, and muscular dystrophies are eagerly awaited. Although no doubt, stem cells will have much to offer in the future, the results of further research still limit their use.

Identifiers

PMID22220178
PMCPMC3246792
OpenAlexW2022916041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.